Publisher Correction: Co-targeting CDK4/6 and AKT with endocrine therapy prevents progression in CDK4/6 inhibitor and endocrine therapy-resistant breast cancer

Affiliations

• ¹ Department of Cancer and Inflammation Research, Institute of Molecular Medicine, University of Southern Denmark, Odense, Denmark. [email protected].
• ² Department of Cancer and Inflammation Research, Institute of Molecular Medicine, University of Southern Denmark, Odense, Denmark.
• ³ Department of Oncology, Institute of Clinical Research, Odense University Hospital, Odense, Denmark.
• ⁴ Garvan Institute of Medical Research, Sydney, NSW, Australia.
• ⁵ St. Vincent's Clinical School, Faculty of Medicine, University of New South Wales Sydney, Sydney, NSW, Australia.
• ⁶ Division of Oncology and Pathology, Department of Clinical Sciences, Lund University, Lund, Sweden.
• ⁷ Department of Pathology, Sydvestjysk Sygehus, Esbjerg, Denmark.
• ⁸ Department of Cancer and Inflammation Research, Institute of Molecular Medicine, University of Southern Denmark, Odense, Denmark. [email protected].
• ⁹ Department of Oncology, Institute of Clinical Research, Odense University Hospital, Odense, Denmark. [email protected].
• ¹⁰ Academy of Geriatric Cancer Research (AgeCare), Odense University Hospital, Odense, Denmark. [email protected].